MREM Press Releases
Take Off To A Christmas Shopping Experience Like No Other With Passport To Shop At IPC Shopping Centre
Bridging communities in the spirit of celebration this year-end through an airport-themed Christmas experience and 18versary Virtual Run KUALA LUMPUR, Malaysia, Dec 8 (Bernama-PRNewswire) — As the borders open and Malaysians prepare to travel again, IPC Shopping Centre brings back the wonders of travelling via flight with an airport-themed Christmas celebration.
Visit China Ningxia, give your soul a vacation
KUALA LUMPUR, Dec 8 (Bernama) — China Ningxia, a stop on ancient Silk Road, also known as the “the Silk Road Post station”, has served as an important passage for transportation and trade between the East and the West in history. Ningxia, where the Yellow River flows through, has been
Sabah and PETRONAS Sign Commercial Collaboration Agreement
KOTA KINABALU, Dec 7 (Bernama) — The Sabah State Government and PETRONAS are pleased to announce the signing today of a Commercial Collaboration Agreement to further enhance the collaboration between the two parties in developing the oil and gas industry in Sabah. The Agreement, which was concluded under the steer
Australian wealth management company, ClearView, harnesses Napier technology in fight against financial crime
SYDNEY, Dec 7 (Bernama-BUSINESS WIRE) — Napier, provider of leading anti-financial crime compliance solutions, has announced that Australian financial services company, ClearView, has adopted its AI-enhanced technology to support anti-money laundering (AML) activities. The technology will enable ClearView to gain better insights into its customers and identify suspicious behaviour more efficiently
Adagene Presents Clinical Data Demonstrating Strong Safety and Early Signals of Efficacy in Cold Tumors Including Pancreatic and Ovarian Cancers for Anti-CTLA-4 Monoclonal Antibody, ADG116, at ESMO-IO 2021
Additional highlights include pharmacodynamic biomarker analyses from ongoing trial of anti-CD137 antibody, ADG106, in combination with anti-PD-1 toripalimab SAN DIEGO and SUZHOU, China, Dec 7 (Bernama-GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced
Juniper Research: Nokia, Ericsson & Druid Software Top Juniper Research Private Networks Competitor Leaderboard
BASINGSTOKE, England, Dec 7 (Bernama-BUSINESS WIRE) — A study from Juniper Research has ranked Nokia, Ericsson and Druid Software as key leaders within the private networks sector for 2021. Private cellular networks are cellular networks managed by or for specific businesses, and do not allow unauthorised access. They are generally used where other
Longevity Science Foundation Launches Decentralised Blockchain Voting Programme
ZUG, Switzerland, Dec 7 (Bernama-BUSINESS WIRE) — The Longevity Science Foundation (LSF) — a Swiss non-profit dedicated to advancing the healthy human lifespan — has announced today it will use blockchain technology in its funding selection process. To do so, the Foundation has created LSF Points, which will be distributed
Tourism Malaysia Named as World’s Leading Country Tourism Board at Uzakrota Global Travel Awards
ISTANBUL, Dec 7 (Bernama) — Tourism Malaysia has won the World’s Leading Country Tourism Board Category once again at the Uzakrota Global Travel Awards 2021, which took place at Madame Tussauds Museum, Istanbul on the 3rd December 2021. Organised by the Uzakrota Travel Summit, the annual event aims to recognise and reward
Adagene Presents Clinical Data Demonstrating Strong Safety and Early Signals of Efficacy in Treatment-Resistant Tumors for Anti-CTLA-4 Monoclonal Antibody, ADG116, at ESMO-IO 2021
– Additional highlights include pharmacodynamic biomarker analyses from ongoing trial of anti-CD137 antibody, ADG106, in combination with anti-PD-1 toripalimab – SAN DIEGO and SUZHOU, China, Dec 7 (Bernama-GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies,
CS Cloud And Cloocus Co Ltd Team Up In Synergistic Collaboration
KUALA LUMPUR, Dec 7 (Bernama) — CS Cloud Sdn Bhd (“CS Cloud”), a subsidiary of Censof Holdings Berhad (“Censof” or the “Group”) signed a joint venture (“JV”) agreement with Cloocus Co. Ltd (“Cloocus Korea”) at a ceremony held today at the Sheraton Hotel Petaling Jaya to facilitate the mutual sharing of